Valantine Hannah - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 15, 2024, Valantine Hannah's relationship to BridgeBio Pharma, Inc. (BBIO) is Director, and currently has 4,679 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BBIO insiders.
Data Source: SEC.
Valantine Hannah - Insider Non-Derivative Transactions of BBIO Common Stock
Valantine Hannah - Insider Non-Derivative Transactions at BBIO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 16, 2024 | Sell -- (Common Stock) | 2915 | 37.75 | 1764 |
| Feb 16, 2024 | M -- (Common Stock) | 2915 | 8.45 | 4679 |
| Jan 17, 2024 | Sell -- (Common Stock) | 2915 | 37.97 | 1764 |
| Jan 17, 2024 | M -- (Common Stock) | 2915 | 8.45 | 4679 |
| Dec 16, 2023 | Sell -- (Common Stock) | 2915 | 36.12 | 1764 |
| Dec 16, 2023 | M -- (Common Stock) | 2915 | 8.45 | 4679 |
| Nov 16, 2023 | Sell -- (Common Stock) | 2915 | 30 | 1764 |
| Nov 16, 2023 | M -- (Common Stock) | 2915 | 8.45 | 4679 |
| Dec 29, 2021 | P -- (Common Stock) | 1891 | 13.18 | 1891 |
| Dec 29, 2021 | P -- (Common Stock) | 1542 | 12.68 | 3433 |